trending Market Intelligence /marketintelligence/en/news-insights/trending/wgzQb4RcMqvCjkqCo2S_Kw2 content esgSubNav
In This List

Medovex, Technology Consult partner to sell Denervex system in Germany

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Blog

Commercial Banking Newsletter June Edition - 2022


Medovex, Technology Consult partner to sell Denervex system in Germany

Medovex Corp. entered into a partnership with Technology Consult Berlin GmbH for distribution of its Denervex system in Germany.

Technology Consult is expected to provide sales, marketing and distribution services.

On March 13, the company said the reimbursement authority in Germany had renewed reimbursement payment coding for its Denervex system technology for the treatment of the facet joint syndrome for 2017.

The coding was released in the diagnosis-related group system in 2017 in Germany and allows for hospitals and outpatient centers to receive reimbursement for the use of the system.

Denervex is not yet commercially available in the EU and the U.S. The system is not yet FDA cleared.